- Title
- Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes
- Creators
- Joshua F Zeidner - University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC. joshua_zeidner@med.unc.eduFlora Mazerolle - MODUSJonathan Norton - Millennium Pharmaceuticals, Inc. a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MAAntoine Regnault - MODUSFjoralba Kristo - Millennium Pharmaceuticals, Inc. a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MAHeather Romero - Millennium Pharmaceuticals, Inc. a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MARobert J Fram - TakedaDouglas V Faller - TakedaMehul Dalal - Millennium Pharmaceuticals, Inc. a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MALionel AdesMikkael A Sekeres - University of Miami
- Publication Details
- Haematologica (Roma), Vol.108(4), p.1196
- Academic Unit
- UMMG Dept of Medicine - Hematology/Oncology; Miller School of Medicine
- Language
- English
- Resource Type
- Journal article
- PMID
- 36475522
- Record Identifier
- 991031784620502976
Journal article
Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes
Haematologica (Roma), Vol.108(4), p.1196
2023-04-01
PMID: 36475522
Metrics
1 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.103 Blood Disorders
- 1.103.155 Acute Myeloid Leukemia
- Web Of Science research areas
- Hematology
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites